IDEAYA Biosciences, Inc.IDYANASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+49.7%
5Y CAGR+47.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+49.7%/yr
vs +33.0%/yr prior
5Y CAGR
+47.5%/yr
Consistent
Acceleration
+16.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
7x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $373.43M | +13.1% |
| 2024 | $330.14M | +114.6% |
| 2023 | $153.81M | +38.2% |
| 2022 | $111.33M | +45.6% |
| 2021 | $76.48M | +43.0% |
| 2020 | $53.50M | +24.3% |
| 2019 | $43.03M | +21.1% |
| 2018 | $35.53M | +152.9% |
| 2017 | $14.05M | - |